Oncology care is increasingly a multidisciplinary endeavour, and radiation therapy
continues to have a key role across the disease spectrum in nearly every cancer. However …

Context Management of bladder cancer (BC) is primarily driven by stage, grade, and
biological potential. Knowledge of each is derived using clinical, histopathological, and …

Background Previous randomised controlled trials comparing bladder preservation with
radical cystectomy for muscle-invasive bladder cancer closed due to insufficient accrual …

The number of cancer survivors continues to increase because of both advances in early
detection and treatment and the aging and growth of the population. For the public health …

Purpose: This multidisciplinary, evidence-based guideline for clinically non-metastatic
muscle-invasive bladder cancer focuses on the evaluation, treatment and surveillance of …

Context Invasive bladder cancer is a frequently occurring disease with a high mortality rate
despite optimal treatment. The European Association of Urology (EAU) Muscle-invasive and …

The number of cancer survivors continues to increase due to the aging and growth of the
population and improvements in early detection and treatment. In order for the public health …

Although there has been considerable progress in reducing cancer incidence in the United
States, the number of cancer survivors continues to increase due to the aging and growth of …

Background Tri-modality therapy (TMT) is a recognized treatment strategy for selected
patients with muscle-invasive bladder cancer (MIBC). Objective Report long-term outcomes …

Purpose Multiple prospective Radiation Therapy Oncology Group (RTOG) protocols have
evaluated bladder-preserving combined-modality therapy (CMT) for muscle-invasive …